Meet the Enemy of Brain Health

What causes Alzheimer's, Parkinson's, and other neurodegenerative diseases? Research shows they are linked to certain proteins gone rogue.
Misfolded proteins of abeta tau synuclein
Share on facebook
Share on twitter
Share on linkedin

What causes Alzheimer’s, Parkinson’s, and other neurodegenerative diseases? In simple terms, they are caused by normal proteins that misfold. Also known as prions, these misfolded proteins drive the progression of Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.

Tracking the different prion biomarkers becomes job one in diagnosing Parkinson’s and Alzheimer’s, unlocking the key to finding effective treatments for these diseases.  Let’s have a look at the prions; we also refer to them as Proteins Gone Rogue.

Did you know that over the past 100 years, we have been flying blind in drug development for Alzheimer’s and Parkinson’s?

Despite spending over $100 billion in drug development and clinical trials, no single drug passes FDA approval so far. So why has there been no effective treatment for Alzheimer’s and Parkinson’s? The culprit — lack of early detection of the biomarkers that cause the disease.

Without early detection, there is no effective way to develop treatments. That is, until now…

For the first time in history, our team of scientists is working to change that, thanks to molecular science advancement.  Watch this video to learn how we track the three types of prions: Abeta, Tau, and Synuclein.

Our breakthrough Prion Detection Science℠ tracks these rogue proteins at the early stages in the brain, decades before the person shows any symptoms. We believe early testing for Alzheimer’s and Parkinson’s is a key pathway in finding a cure for Alzheimer’s and Parkinson’s.

Get updates on Amprion’s news and brain health videos.


Related Posts on Early Prion Detection:

Join the Fight

Stay Ahead of the Curve on Brain Health

Join the Fight

Stay Ahead of the Curve on Brain Health

Related Articles

parkinzheimer page featured image


What’s Is It? And how does it impact the early diagnosis of Parkinson’s and Alzheimer’s?